We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+44.49%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$1.35B
AUM Growth
+$376M
Cap. Flow
+$77.8M
Cap. Flow %
5.75%
Top 10 Hldgs %
52.62%
Holding
81
New
21
Increased
33
Reduced
5
Closed
7

Top Buys

Rank Stock Value
1
HCAT icon
Health Catalyst
HCAT
+$26.6M
2
ARWR icon
Arrowhead Research
ARWR
+$26.5M
3
PRTA icon
Prothena Corp
PRTA
+$24.3M
4
HALO icon
Halozyme
HALO
+$23.9M
5
FPRX
Five Prime Therapeutics, Inc.
FPRX
+$19.6M

Top Sells

Rank Stock Value
1
IMMU
Immunomedics Inc
IMMU
+$134M
2
AMRN
Amarin Corp
AMRN
+$9.41M
3
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$9.22M
4
KRMD icon
KORU Medical Systems
KRMD
+$7.76M
5
CDNA icon
CareDx
CDNA
+$5.94M

Sector Composition

Rank Sector Weight
1 Healthcare 86.3%
2 Communication Services 3.46%
3 Energy 0.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CDNA icon
1
CareDx
CDNA
$2.26B
$130M 9.58%
1,787,637
-102,576
-5% -$5.94M
HALO icon
2
Halozyme
HALO
$9.79B
$110M 8.13%
2,571,892
+665,103
+35% +$23.9M
SPNE
3
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$93.4M 6.91%
5,351,493
+246,256
+5% +$3.75M
OXFD
4
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$86.4M 6.39%
4,946,629
+307,430
+7% +$4.31M
ARWR icon
5
Arrowhead Research
ARWR
$11.9B
$54.1M 4%
704,449
+413,962
+143% +$26.5M
OMCL icon
6
Omnicell
OMCL
$1.61B
$52.8M 3.91%
440,246
+19,892
+5% +$1.95M
GKOS icon
7
Glaukos
GKOS
$9.83B
$51M 3.78%
678,307
+28,018
+4% +$1.77M
MODN
8
DELISTED
MODEL N, INC.
MODN
$46.7M 3.46%
1,310,013
+378,046
+41% +$13.1M
ATRC icon
9
AtriCure
ATRC
$1.92B
$45.1M 3.33%
809,310
+248,292
+44% +$10.7M
HCAT icon
10
Health Catalyst
HCAT
$154M
$42.3M 3.13%
971,897
+721,144
+288% +$26.6M
AXGN icon
11
Axogen
AXGN
$2.27B
$38.3M 2.83%
2,139,134
+409,699
+24% +$6.02M
INSM icon
12
Insmed
INSM
$21.4B
$35.7M 2.64%
1,071,219
+45,878
+4% +$1.68M
KRMD icon
13
KORU Medical Systems
KRMD
$189M
$35.3M 2.62%
5,871,364
-1,385,902
-19% -$7.76M
TEVA icon
14
Teva Pharmaceuticals
TEVA
$40.8B
$32.7M 2.42%
3,391,412
+1,531,387
+82% +$14.7M
YMAB
15
DELISTED
Y-mAbs Therapeutics
YMAB
$31.5M 2.33%
635,652
+27,459
+5% +$1.27M
RARE icon
16
Ultragenyx Pharmaceutical
RARE
$2.45B
$29.6M 2.19%
213,887
+28,917
+16% +$3.43M
KRYS icon
17
Krystal Biotech
KRYS
$10.1B
$29.5M 2.18%
491,740
+27,077
+6% +$1.35M
XENT
18
DELISTED
Intersect ENT, Inc
XENT
$28M 2.07%
1,222,961
+34,427
+3% +$655K
NEO icon
19
NeoGenomics
NEO
$1.96B
$27.8M 2.06%
517,091
-96,011
-16% -$4.34M
FPRX
20
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$26.6M 1.97%
+1,563,618
New +$19.6M
GMAB icon
21
Genmab
GMAB
$17.7B
$25.9M 1.92%
637,084
+33,214
+6% +$1.24M
TNDM icon
22
Tandem Diabetes Care
TNDM
$1.34B
$25.6M 1.89%
267,274
+10,069
+4% +$1.04M
ARNA
23
DELISTED
Arena Pharmaceuticals Inc
ARNA
$24.7M 1.83%
321,967
+56,628
+21% +$4.24M
PRTA icon
24
Prothena Corp
PRTA
$425M
$24.7M 1.83%
+2,056,453
New +$24.3M
OPRX icon
25
OptimizeRx
OPRX
$114M
$21.4M 1.58%
685,700
+95,700
+16% +$2.34M
1
2 3 4

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q4 2020 Portfolio in Review

As of Q4 2020, First Light Asset Management held 81 positions worth $1.35B, up 38% from $976M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

First Light Asset Management deployed $77.8M of net new capital in Q4 2020, opening 21 new positions and adding to 33 existing holdings. Its largest new stake was Prothena Corp: 2,056,453 shares worth $24.7M.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, up from 72% a quarter earlier, followed by Communication Services and Energy.

On the sell side, the largest reduction was KORU Medical Systems, an estimated $7.76M trimmed.

  • First Light Asset Management's largest Q4 2020 buy was Prothena Corp: 2,056,453 shares worth $24.7M.
  • First Light Asset Management added most to Health Catalyst in Q4 2020, an estimated $26.6M increase.
  • First Light Asset Management's biggest Q4 2020 reduction was KORU Medical Systems, cutting an estimated $7.76M.
  • First Light Asset Management fully exited Immunomedics Inc in Q4 2020, selling an estimated $134M.
  • First Light Asset Management's ten largest holdings make up 53% of its $1.35B portfolio in Q4 2020.
  • First Light Asset Management opened 21 new positions and closed 7 in Q4 2020.
  • First Light Asset Management's portfolio value rose 38% quarter-over-quarter to $1.35B.

Based on First Light Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.